• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染的诊断:分子方法。

Diagnosis of Clostridium difficile infection: the molecular approach.

机构信息

National Reference Laboratory for Clostridium difficile, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.

出版信息

Future Microbiol. 2013 Dec;8(12):1587-98. doi: 10.2217/fmb.13.129.

DOI:10.2217/fmb.13.129
PMID:24266358
Abstract

Diagnosis of Clostridium difficile infection is based on clinical presentation and laboratory tests. Although numerous laboratory methods are now available, the diagnosis of C. difficile infection remains challenging. Nucleic acid amplification tests (NAATs) are the most recent marketed methods. These methods detect genes for toxins A and/or B. They are very sensitive compared with the reference method (toxigenic culture) and are thus very promising, despite their cost. However, a positive NAAT result must be interpreted with caution owing to the possible detection of asymptomatic carriers of toxigenic strains who may have diarrhea for other reasons. The place of NAATs in current diagnostic strategies needs to be better defined, but the rapidity of the result is interesting for early recognition of the disease.

摘要

艰难梭菌感染的诊断基于临床症状和实验室检查。虽然现在有许多实验室方法,但艰难梭菌感染的诊断仍然具有挑战性。核酸扩增检测(NAAT)是最新上市的方法。这些方法检测毒素 A 和/或 B 的基因。与参考方法(产毒培养)相比,它们具有很高的灵敏度,因此尽管成本较高,但非常有前途。然而,由于可能检测到产毒株的无症状携带者,他们可能因其他原因出现腹泻,因此必须谨慎解释阳性 NAAT 结果。NAAT 在当前诊断策略中的地位需要进一步明确,但结果的快速性对于早期识别疾病很有意义。

相似文献

1
Diagnosis of Clostridium difficile infection: the molecular approach.艰难梭菌感染的诊断:分子方法。
Future Microbiol. 2013 Dec;8(12):1587-98. doi: 10.2217/fmb.13.129.
2
Molecular methods in the diagnosis of Clostridium difficile infections: an update.分子方法在艰难梭菌感染诊断中的应用:最新进展。
Expert Rev Mol Diagn. 2013 Sep;13(7):681-92. doi: 10.1586/14737159.2013.829705.
3
Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.前瞻性评估 Meridian Illumigene™ 环介导扩增检测法和 Gen Probe ProGastro™ Cd 聚合酶链反应检测法,用于直接从粪便样本中检测产毒艰难梭菌。
Diagn Microbiol Infect Dis. 2012 Jan;72(1):8-13. doi: 10.1016/j.diagmicrobio.2011.09.008. Epub 2011 Oct 19.
4
Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.BD Max艰难梭菌检测法与GenomEra艰难梭菌分子检测法在常规样本容器及粪便拭子中粪便样本中产毒艰难梭菌检测方面的比较
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):1005-9. doi: 10.1007/s10096-015-2320-2. Epub 2015 Jan 24.
5
Optimizing the Laboratory Diagnosis of Clostridium difficile Infection.优化艰难梭菌感染的实验室诊断
Clin Lab Med. 2015 Jun;35(2):299-312. doi: 10.1016/j.cll.2015.02.003. Epub 2015 Mar 18.
6
Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.克服有效识别和诊断艰难梭菌感染的障碍。
Clin Microbiol Infect. 2012 Dec;18 Suppl 6:13-20. doi: 10.1111/1469-0691.12057.
7
Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.用于粪便中产毒艰难梭菌分子检测的新型便携式平台:一项诊断准确性研究。
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):783-789. doi: 10.1007/s10096-016-2860-0. Epub 2016 Dec 17.
8
Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea.疑似艰难梭菌相关性腹泻时,用核酸扩增试验替代传统酶免疫分析法的临床影响。
Am J Infect Control. 2013 Apr;41(4):373-5. doi: 10.1016/j.ajic.2012.04.329. Epub 2012 Oct 5.
9
Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.商用分子检测方法在粪便中产毒艰难梭菌检测的比较:BD GeneOhm Cdiff、Xpert C. difficile 和 illumigene C. difficile。
J Microbiol Methods. 2012 Aug;90(2):83-5. doi: 10.1016/j.mimet.2012.04.017. Epub 2012 Apr 28.
10
Accuracy of loop-mediated isothermal amplification for the diagnosis of Clostridium difficile infection: a systematic review.环介导等温扩增技术诊断艰难梭菌感染的准确性:一项系统评价
Diagn Microbiol Infect Dis. 2015 May;82(1):4-10. doi: 10.1016/j.diagmicrobio.2015.02.007. Epub 2015 Feb 23.

引用本文的文献

1
Retrospective Definition of PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study.基于全基因组多态性的PCR核糖型回顾性定义:一项原理验证研究
Diagnostics (Basel). 2020 Dec 12;10(12):1078. doi: 10.3390/diagnostics10121078.
2
Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.单细胞阵列分析检测艰难梭菌毒素的敏感性与传统实验室检测算法的比较。
J Clin Microbiol. 2018 Jul 26;56(8). doi: 10.1128/JCM.00452-18. Print 2018 Aug.
3
Current knowledge on the laboratory diagnosis of infection.
关于感染实验室诊断的当前知识。
World J Gastroenterol. 2017 Mar 7;23(9):1552-1567. doi: 10.3748/wjg.v23.i9.1552.
4
Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.样本到结果的分子传染病检测:临床意义、局限性及潜力
Expert Rev Mol Diagn. 2016;16(3):323-41. doi: 10.1586/14737159.2016.1134325. Epub 2016 Jan 11.
5
Role of microbiota and innate immunity in recurrent Clostridium difficile infection.微生物群和先天免疫在复发性艰难梭菌感染中的作用。
J Immunol Res. 2014;2014:462740. doi: 10.1155/2014/462740. Epub 2014 Jun 5.